ArticleJournal of hematology & oncology2025

PSMA-targeted CAR-macrophages drive glycolytic reprogramming for enhanced prostate cancer immunotherapy.

Yangli Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.